MEDTIDE (03880) completed the full circulation of H shares.
Teda Pharmaceuticals (03880) announced that 68,201,100 non-listed shares have been converted to H shares on March 9, 2026, and the conversion of H shares will commence trading on the Stock Exchange of Hong Kong on the morning of March 10, 2026.
MEDTIDE (03880) announced that 68,201,100 shares of non-listed stock have been converted to H shares on March 9, 2026, and the conversion to H shares will be listed on the Hong Kong Stock Exchange on March 10, 2026, at 9:00 am.
Related Articles

Target price slashed to $315! Citi expects Adobe (ADBE.US) Q1 earnings to be "flat", market closely watching if AI can break the deadlock.

CNE TECH CORP (00611) announces profit increase, expected to increase by about 40% to 50% compared to the previous year in 2025.

Fujian Torch Electron Technology (603678.SH) plans to launch the fifth phase of the employee stock ownership plan.
Target price slashed to $315! Citi expects Adobe (ADBE.US) Q1 earnings to be "flat", market closely watching if AI can break the deadlock.

CNE TECH CORP (00611) announces profit increase, expected to increase by about 40% to 50% compared to the previous year in 2025.

Fujian Torch Electron Technology (603678.SH) plans to launch the fifth phase of the employee stock ownership plan.

RECOMMEND





